Kornitzer Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
NAMA
Kornitzer Capital Management's CDNA Position: Q1 2022 in Review
Kornitzer Capital Management sold out of CareDx (CDNA) in Q1 2022, closing a stake of 244,679 shares — an estimated $11.1M sold.
Kornitzer Capital Management first reported a position in CDNA in Q4 2018 and held it in 13 quarters. The position peaked at $22.8M in Q4 2020. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.
- Kornitzer Capital Management reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
- Kornitzer Capital Management sold 244,679 CareDx shares in Q1 2022, an estimated $11.1M.
- Kornitzer Capital Management first reported a position in CareDx in Q4 2018 and held it in 13 quarters.
- Kornitzer Capital Management's CareDx position peaked at $22.8M in Q4 2020.
- 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.
Based on Kornitzer Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.